Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05679245
Other study ID # CS01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 28, 2023
Est. completion date March 2024

Study information

Verified date December 2022
Source Parc de Salut Mar
Contact Alicia Valiente-Gómez, PhD
Phone 933268500
Email avaliente@psmar.cat
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this observational study is to learn about how many people have post-traumatic stress disorder and related symptoms in the general population of people without any mental illness in the Barcelona region of Catalonia, Spain. The main questions it aims to answer are: - What is the prevalence of post-traumatic stress disorder in a sample of healthy controls without other mental disorders? - What is the prevalence of trauma-related symptoms in a sample of healthy controls without mental illness? - What is the prevalence of dissociative symptoms (including symptoms of depersonalisation and somatoform dissociation) in a sample of healthy controls without mental illness? - What is the prevalence of recent and childhood traumatic life events in a sample of healthy controls without mental illness? - What is the prevalence of difficulties in psychosocial functioning in healthy controls without mental illness? - What is the prevalence of depressive symptoms in healthy controls without mental illness? - What is the prevalence of general psychiatric symptoms in healthy controls without mental illness? Participants will be asked to take part in an online screening programme, and then to come to an interview with a clinician who will apply validated scales to test the above.


Description:

This is a study to provide normative data for the prevalence of traumatic life events, post-traumatic stress disorder and trauma-related symptoms, and their impact on psychosocial functioning, and affective symptoms in healthy controls (i.e. without mental illness) in the Barcelona region of Catalonia, Spain.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date March 2024
Est. primary completion date March 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - to be an adult (18-65 years inclusive) Exclusion Criteria: - to have a mental disorder except for post-traumatic stress disorder, determined by application of the Mini International Neuropsychiatric Interview (MINI) - active suicidal ideation - presence of organic brain disease - presence of somatic diseases such as fibromyalgia or chronic fatigue syndrome - presence of autoimmune diseases such as HIV or AIDS

Study Design


Intervention

Diagnostic Test:
Assessment for exposure to psychological trauma and related symptoms
To be assessed for exposure to traumatic life events, post-traumatic stress disorder, trauma-related symptoms, dissociative symptoms, affective symptoms, and psychosocial functioning.

Locations

Country Name City State
Spain Alicia Valiente Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Parc de Salut Mar

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of post-traumatic stress disorder in a sample of healthy controls without mental disorder Prevalence of post-traumatic stress disorder according to criteria of the Diagnostic and Statistical Manual of Mental Disorders - 5th Edition, as per the Global Evaluation of Post-traumatic Stress Disorder Scale (EGEP-5), which assesses the presence or absence of post-traumatic stress disorder. cross-sectional, baseline
Primary Prevalence of trauma symptoms in a sample of healthy controls without mental disorder Prevalence of trauma-related symptoms according to the Impact of Events Scale-Revised (IES-R), which is scored on a Likert scale with a maximum score of 110, with higher scores meaning a greater level of trauma symptoms. cross-sectional, baseline
Primary Prevalence of dissociative symptoms in a sample of healthy controls without mental disorder Prevalence of dissociative symptoms according to the Dissociative Experiences Scale (DES). The final score is out of 100, with higher scores meaning a greater number of symptoms. cross-sectional, baseline
Secondary Prevalence of depressive symptoms in a sample of healthy controls without mental disorder Prevalence of depressive symptoms according to the Hamilton Depression Rating Scale (HDRS), which can provide a total score between 0 and 63, with higher scores meaning greater depressive symptoms. cross-sectional, baseline
Secondary Prevalence of psychiatric symptoms in a sample of healthy controls without mental disorder Prevalence of psychiatric symptoms according to the Brief Psychiatric Rating Scale (BPRS). The first 18 items on this scale provide a total score from 0 to 146, with higher scores signifying more severe psychiatric symptoms, while item 19 provides an estimate of severity of illness on a Likert scale from 1 to 7. cross-sectional, baseline
Secondary Prevalence of symptoms of somatoform dissociation in a sample of healthy controls without mental disorder Prevalence of symptoms of somatoform dissociation according to the Somatoform Dissociation Questionnaire (SDQ-20). Each item is scored on a Likert scale from 1 to 5, up to a total score of 100. Higher scores denote more somatoform symptoms. cross-sectional, baseline
Secondary Prevalence of depersonalisation dissociative symptoms in a sample of healthy controls without mental disorder Prevalence of depersonalisation dissociative symptoms according to the Cambridge Depersonalisation Scale. Each item is scored for frequency (0 to 4) and duration (1 to 6), and these scores are summed together to create a total score. Higher scores indicate greater levels of dissociative symptoms. cross-sectional, baseline
Secondary Prevalence of difficulties in psychosocial functioning in a sample of healthy controls without mental disorder Prevalence of difficulties in psychosocial functioning according to the Functioning Assessment Short Test (FAST). Each item on this scale is scored on a Likert scale of 0 to 3, providing a total score between 0 and 72. Higher scores indicate a greater degree of difficulty in functioning. cross-sectional, baseline
Secondary Prevalence of childhood trauma events (physical, sexual, or emotional abuse, and physical or emotional neglect) in a sample of healthy controls without mental disorder Prevalence of childhood trauma experiences according to the Childhood Trauma Questionnaire (CTQ). This scale provides a score for each subscale of physical, sexual, or emotional abuse, and physical or emotional neglect, with scores categorised as ranging from none to severe. cross-sectional, baseline
Secondary Prevalence of recent stressful life events in a sample of healthy controls without mental disorder Prevalence of recent stressful life events in the previous year according to the Social Readjustment Rating Scale (Holmes & Rahe). This scale provides the number of stressful events. Each event has a weighted score which is summed to create a total score, with higher scores signifying a greater risk of stress-related illness. cross-sectional, baseline
See also
  Status Clinical Trial Phase
Recruiting NCT04317820 - Deep Brain Reorienting in Post-traumatic Stress Disorder N/A
Completed NCT05112003 - Translingual Neurostimulation for the Virtual Treatment of Post-Traumatic Stress Disorder: A Feasibility Pilot N/A
Recruiting NCT04518267 - Anger and Psychotrauma: Data From Military and Civilians
Completed NCT02502604 - Cognitive Training Program for Individuals With Depression and Post-Traumatic Stress Disorder N/A
Terminated NCT02234687 - A mGlu2/3 Agonist in the Treatment of PTSD Phase 1
Completed NCT02256566 - Cognitive Training for Mood and Anxiety Disorders N/A
Completed NCT01738308 - The Effects of Healing Touch on Post Operative Pediatric Patients N/A
Terminated NCT02520726 - PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims Phase 4
Completed NCT02213900 - Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy Phase 4
Completed NCT01517711 - Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD) Phase 4
Completed NCT01437891 - Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder (PTSD) and Gulf War Fibromyalgia (GWF) N/A
Completed NCT01998100 - Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD) Phase 3
Completed NCT01199107 - Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD) Phase 3
Completed NCT01231711 - Improving Quality-of-life and Depressive Symptoms of Combat Veterans Via Internet-based Intervention Phase 1
Completed NCT00348036 - Group Intervention for Interpersonal Trauma N/A
Completed NCT00838006 - Psychophysiologic Predictors of Post-deployment Mental Health Outcomes N/A
Completed NCT00680524 - Telephone-based Care for OEF/OIF Veterans With PTSD N/A
Completed NCT00525226 - Evaluating the Effects of Stress in Pregnancy N/A
Completed NCT00158262 - Effect of Propranolol on Preventing Posttraumatic Stress Disorder Phase 4
Completed NCT00127673 - Comparison of Two Treatments for Post-Traumatic Stress Disorder Phase 3